Thermo Fisher Scientific Other Comprehensive Income (Loss) decreased by 300.0% to -$6.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 300.0%, from $3.00M to -$6.00M.
tmo_other_comprehensive_income| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$68.00M | -$24.00M | -$11.00M | $4.00M | -$3.00M | $3.00M | -$7.00M | -$1.00M | -$3.00M | -$3.00M | $6.00M | $3.00M | -$6.00M |
| QoQ Change | — | +64.7% | +54.2% | +136.4% | -175.0% | +200.0% | -333.3% | +85.7% | -200.0% | +0.0% | +300.0% | -50.0% | -300.0% |
| YoY Change | — | — | — | +105.9% | +87.5% | +127.3% | -275.0% | +66.7% | -200.0% | +57.1% | +700.0% | +200.0% | -300.0% |